TransDigm price target raised to $1,550 from $1,275 at Morgan Stanley

Morgan Stanley raised the firm’s price target on TransDigm to $1,550 from $1,275 and keeps an Overweight rating on the shares. The firm remains positive on all of TransDigm’s primary end markets and continues to see a robust pipeline for commercial aftermarket, adding that management execution “continues to trend positively and surprise to the upside.”